Lv12
40 积分 2022-10-07 加入
Risk of hepatic decompensation but not hepatocellular carcinoma decreases over time in patients with hepatitis B surface antigen loss
2小时前
已完结
Type 2 Diabetes mellitus as an independent predictor of significant fibrosis in treatment-naïve chronic hepatitis B patients with concurrent hepatic steatosis
21小时前
已完结
Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study
2个月前
已完结
Type 2 Diabetes mellitus as an independent predictor of significant fibrosis in treatment-naïve chronic hepatitis B patients with concurrent hepatic steatosis
2个月前
已完结
Prevalence and predictors of cirrhosis and portal hypertension in the united states
3个月前
已完结
Efimosfermin alfa (BOS-580), a long-acting FGF21 analogue, in participants with phenotypic metabolic dysfunction-associated steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial
3个月前
已完结
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
4个月前
已完结
皖公网安备34019202002308
